Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411756 · ClinicalTrials.gov registry record · NA
Physical Activity Centers Empowerment
A NA study of Colorectal Neoplasms, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT06411756: Active NA study of Colorectal Neoplasms, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT06411756 is a NA study of Colorectal Neoplasms that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 21 participants, below the 576-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06411756, a NA study of Colorectal Neoplasms, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study tests the feasibility of the Physical Activity Centers Empowerment (PACE) physical activity intervention for African American individuals diagnosed with colorectal cancer. Feasibility will be measured as intervention reach, effectiveness, adoption, implementation, and maintenance. Seventy-two subjects will be recruited to conduct a pilot two-group, randomized repeated measures study.
Primary Outcome
Feasibility Reach- Recruitment is measured by the number of participants screened, ineligible, eligible, enrolled and declined participation.
Conditions Studied
Interventions
- BEHAVIORAL Narrative videos
- BEHAVIORAL A Fitbit activity tracker
- OTHER Daily text message
- OTHER Monthly Zoom meeting
- OTHER Website access
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What the registry record for NCT06411756 still lists
NCT06411756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 576-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Colorectal Neoplasms appearing as the primary indexed condition, and to 5 interventions - of which Narrative videos is the first listed.
NCT06411756 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06411756 about?
NCT06411756 is a clinical study titled "Physical Activity Centers Empowerment". This research study tests the feasibility of the Physical Activity Centers Empowerment (PACE) physical activity intervention for African American individuals diagnosed with colorectal cancer. Feasibility will be measured as intervention reach, effectiveness, adoption, implementation, and maintenanc...
What is the current status of trial NCT06411756?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2024-08-14. Estimated completion is 2027-01-31.
What conditions does trial NCT06411756 study?
This clinical trial studies the following conditions: Colorectal Neoplasms.
What interventions are being tested in trial NCT06411756?
The interventions under investigation include: Narrative videos (BEHAVIORAL), A Fitbit activity tracker (BEHAVIORAL), Daily text message (OTHER), Monthly Zoom meeting (OTHER), Website access (OTHER).
Who is sponsoring clinical trial NCT06411756?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06411756 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06411756's enrollment target sits among peer trials
21 52nd of 54 higher than 3 of 54 other Colorectal Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
RECRUITING · NA
-
My Best GI Eating Study
ACTIVE NOT RECRUITING · NA
-
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
COMPLETED · NA
-
Underwater Resection of Non-pedunculated Colorectal Lesions
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
-
Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Testing Kit on Colorectal Cancer Screening Rates
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI